Novosteo, a Purdue University spin-out, has secured $500,000 in seed funding. The investor was Research Bridge Partners. Novosteo is developing a novel injectable-targeted drug for broken and compromised bones.
Source: Press Release
Novosteo, a Purdue University spin-out, has secured $500,000 in seed funding. The investor was Research Bridge Partners. Novosteo is developing a novel injectable-targeted drug for broken and compromised bones.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination